electroCore, Inc. SEC Filings

electroCore, Inc. reported second-quarter 2026 net sales of $9.5 million, up approximately 28% year-over-year, led by U.S. prescription sales to the Veterans Affairs system and general wellness products. Quell revenue reached $1.3 million, growing about 700% versus 2025, while Truvaga revenue was $1.3 million, up 27% year-over-year but down 17% sequentially as marketing spend was reduced.

Gross profit was $8.2 million with gross margin of 86.5%. Operating expenses rose to $10.9 million, reflecting higher sales and marketing and R&D, partly offset by lower general and administrative costs. GAAP net loss narrowed to $3.1 million, or $0.33 per share, and adjusted EBITDA net loss improved to $1.8 million. Cash, cash equivalents and marketable securities totaled about $10.0 million at June 30, 2026, with the balance sheet showing a stockholders’ deficit of $2.8 million.

The company is restructuring its commercial organization, expanding sales regions, adding 1099 representatives, revising incentives, and consolidating federal contracting through Lovell Government Services to lower fees and improve scalability. Management raised full-year 2026 revenue guidance to greater than 30% growth over 2025 and expects to achieve positive adjusted EBITDA in the third quarter of 2027.

electroCore, Inc. is soliciting proxies for a fully virtual 2026 annual meeting on September 8, 2026 at 9:00 a.m. Eastern Time via www.virtualshareholdermeeting.com/ECOR2026. Stockholders of record as of July 10, 2026, holding 9,015,885 common shares, may vote.

Three proposals are up for vote: electing three Class II directors (Thomas J. Errico, M.D., James C. Theofilos and Elena Bonfiglioli) to terms expiring at the 2029 meeting; ratifying CBIZ CPAs P.C. as independent auditor for 2026; and a non‑binding “Say on Pay” advisory vote on named executive officer compensation. The Board recommends voting FOR all three proposals.

The company highlights a six‑member, classified and Nasdaq‑independent board with audit, compensation, and nominating and governance committees, an independent chair, and a risk‑oversight framework. 2025 total pay was 1,636,687 for former CEO Daniel S. Goldberger and 707,480 for CFO and Interim President Joshua S. Lev, reflecting a mix of salary, cash bonuses and equity awards. Major stockholders include several >5% holders, while directors and named executives as a group beneficially own 7.8% of outstanding shares.

electroCore, Inc. former officer and director Daniel S. Goldberger reported an open-market sale of 80,000 shares of common stock at a weighted average price of $6.80 per share. According to the filing, these shares were sold in multiple transactions at prices ranging from $6.00 to $8.52 per share between April 23, 2026 and May 26, 2026, subject to Rule 144. Following these transactions, he directly holds 211,471 shares of electroCore common stock.

electroCore, Inc. Chief Financial Officer and Interim President Joshua S. Lev reported an open-market sale of 6,667 shares of Common Stock on May 28, 2026 at a weighted average price of $9.00 per share.

After this transaction, he directly owned 84,889 shares, including 2,889 shares of Common Stock and 82,000 shares issuable under previously granted RSUs that vest over several dates through late 2029, subject to continued service and certain change-in-control conditions.

electroCore, Inc. filed a Form 144 notice reporting insider transactions in Common Stock. The filing lists Restricted Stock Units granted on 01/12/2024 (5,334 RSUs) and 01/15/2025 (1,333 RSUs) and records a sale of 3,000 shares on 05/22/2026 for $19,500.

The excerpt also lists Common Stock information with an adjacent figure 8,295,707 and the date 05/27/2026; the filing shows the transactions and grant dates but does not state additional proceeds treatment or broader offering mechanics.

ECOR filed a Form 144 notice reporting proposed sales of Common stock by holders who received shares as payment for services rendered and as compensation. The excerpt lists multiple grant dates and amounts, including several 3,333-share entries and a 72,034-share grant dated 05/16/2026.

electroCore director Thomas J. Errico increased his stake in the company through open-market buying. On May 21, 2026, he purchased 9,992 shares of electroCore common stock at $5.99 per share in an open-market transaction. This followed a small acquisition of 8 shares on May 20, 2026 classified under Rule 16a-6.

After these transactions, Errico directly owns 360,071 shares of common stock. A footnote explains that his broader holdings also include 259,106 shares owned directly, 1,296 shares held by a family trust, 11,000 shares in a trust for his benefit, 8,872 unvested shares underlying deferred stock units, and 69,797 shares that have vested from previously issued deferred stock units.

electroCore, Inc. executive Joshua S. Lev, the CFO and Interim President, sold 3,000 shares of Common Stock at $6.50 per share on May 22, 2026. According to the filing, this sale was made solely to cover tax withholding obligations triggered by the vesting and settlement of previously granted Restricted Stock Units.

After the transaction, Lev directly holds 91,556 shares of Common Stock. He also has 82,000 additional shares subject to RSUs scheduled to vest between December 31, 2026 and January 26, 2029, contingent on continued service and certain change-in-control protections.

ECOR filed a Form 144 reporting a proposed sale of 45,000 shares of Common Stock. The filing lists Charles Schwab & Co as the broker and an aggregate value of $291,600 with a filing date shown as 05/14/2026.

The filing also records a prior sale by Daniel Goldberger of 16,072 shares on 04/10/2026 for $96,753. The 45,000 shares are linked to an Equity Compensation entry dated 06/30/2021.